C83.22 Mixed small and large cell (diffuse) non-Hodgkin's lymphoma, intrathoracic lymph nodes

Name of the Condition

• Mixed small and large cell (diffuse) non-Hodgkin's lymphoma, intrathoracic lymph nodes
• Also known as ICD-10 code C83.22

Summary

Mixed small and large cell (diffuse) non-Hodgkin's lymphoma is a subtype of non-Hodgkin lymphoma characterized by the malignant proliferation of both small and large lymphoid cells in a diffuse pattern. It typically involves abnormal growth of B-cells or T-cells in the intrathoracic lymph nodes, without forming follicular structures. This condition is part of the broader category of non-follicular lymphomas and may present with variable clinical behavior depending on the specific cell composition and distribution.

Causes

The exact cause of mixed small and large cell (diffuse) non-Hodgkin's lymphoma remains unknown. It is thought to involve genetic mutations or abnormalities in lymphoid cell development, though specific triggers are not well-defined. Research suggests potential links to immune system dysregulation or prior infections, but no definitive etiology has been established.

Risk Factors

• Age: More common in older adults.
• Family history of lymphoma.
• Prior exposure to radiation or certain chemicals.
• Chronic infections, such as hepatitis C or HIV.
• Immunosuppressive conditions or treatments.

Symptoms

• Swollen, painless lymph nodes in the chest or thoracic region.
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.
• Persistent cough or shortness of breath.

Diagnosis

Diagnosis involves a combination of physical examination, imaging tests (e.g., CT or PET scans) to identify affected areas, biopsy of lymph nodes or tissues for laboratory analysis, and blood tests to assess overall health and detect abnormal cell markers.

Treatment Options

• Chemotherapy: Systemic drugs to target and kill cancer cells.
• Immunotherapy: Uses the body's immune system to fight cancer cells.
• Radiation Therapy: High-energy radiation to target localized tumors.
• Targeted Therapy: Drugs that target specific cancer cell characteristics.
• Stem Cell Transplant: For advanced or recurrent cases.

Prognosis and Follow-Up

Prognosis varies based on factors like stage, cell type, and overall health. Regular follow-up with imaging and blood tests is essential to monitor for recurrence or progression. Treatment response and long-term outcomes depend on individual patient factors.

Complications

• Spread of cancer to other organs or tissues.
• Infections due to weakened immune system.
• Side effects from treatments (e.g., fatigue, nausea, or organ damage).
• Respiratory issues if lymph nodes compress airways.

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid known carcinogens, such as tobacco or excessive radiation exposure.
• Manage chronic infections or immunosuppressive conditions with medical guidance.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, night sweats, or respiratory symptoms like cough or shortness of breath.

Tips for Medical Coders

Document the specific location (intrathoracic lymph nodes) and confirm the mixed small and large cell (diffuse) histology to ensure accurate coding. Include details about biopsy results, imaging findings, and clinical presentation to support code assignment.